1. S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
   Sikha Morang et al, 2024, OMICS: A Journal of Integrative Biology CrossRef
2. Long Noncoding RNA MALAT1 Interacts with miR-124-3p to Modulate Osteosarcoma Progression by Targeting SphK1
   Bin Liu et al, 2021, Journal of Oncology CrossRef
3. Crucial Role of RLIP76 in Promoting Glycolysis and Tumorigenesis by Stabilization of HIF-1α in Glioma Cells Under Hypoxia
   Qi Wang et al, 2022, Molecular Neurobiology CrossRef
4. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma
   Renna Qiu et al, 2020, Drug Delivery CrossRef
5. The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
   Chang Liu et al, 2021, Frontiers in Oncology CrossRef
6. Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity
   Milad Ashrafizadeh et al, 2020, Pharmaceutics CrossRef
7. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
   Kyu Sic You et al, 2021, Pharmaceuticals CrossRef
8. Evaluation of the Effect of Nutritional Intervention on Patients with Nasopharyngeal Carcinoma
   Fan Lin et al, 2022, Journal of Healthcare Engineering CrossRef
9. MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism
   An Liu et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef
10. A novel risk score model based on glycolysis‐related genes and a prognostic model for predicting overall survival of osteosarcoma patients
    Wenhao Chen et al, 2022, Journal of Orthopaedic Research CrossRef
11. Sphingosine Kinase Inhibition Enhances Dimerization of Calreticulin at the Cell Surface in Mitoxantrone-Induced Immunogenic Cell Death
    Asvelt J. Nduwumwami et al, 2021, Journal of Pharmacology and Experimental Therapeutics CrossRef
12. The nuclear export protein exportin‐1 in solid malignant tumours: From biology to clinical trials
    Chuanxi Lai et al, 2024, Clinical and Translational Medicine CrossRef
13. Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway
    Khem Raj Limbu et al, 2022, Molecules CrossRef
14. Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
    Sepideh Mirzaei et al, 2021, Antioxidants CrossRef
15. The Warburg effect on radioresistance: Survival beyond growth
    Hyunkoo Kang et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
16. Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance
    Milad Ashrafizadeh et al, 2022, Expert Opinion on Drug Delivery CrossRef
17. The roles of glycolysis in osteosarcoma
    Zuxi Feng et al, 2022, Frontiers in Pharmacology CrossRef
18. YTHDF1-mediated sphingosine kinase 2 upregulation alleviates bupivacaine-induced neurotoxicity via the PI3K/AKT axis
    Ru Yuan et al, 2024, Human & Experimental Toxicology CrossRef